,i  #aafth ,,congress  #ast ,session    
,h4 ,r4 #acjc  ,,in ,,the ,,house ,,of  
,,representatives  ,february #ae1       
#bjai,mr4 ,foster introduced the        
following bill2 which was referred to   
the ,committee on ,energy and ,commerce1
 and in addition to the ,committee on   
,natural ,resources1 for a period to be 
subsequently determined by the ,speaker1
 in each case for consideration of such 
provisions as fall within the           
jurisdiction of the committee concerned 
,a ,,bill  ,to direct the ,comptroller  
,general of the ,united ,states to      
evaluate and report on the inpatient and
 outpatient treatment capacity1         
availability1 and needs of the ,united  
,states4  #a4 ,short title ,this ,act   
may be cited as the ,examining ,opioid  
,treatment ,infrastructure ,act of      
#bjai4  #b4 ,study on treatment         
infrastructure ,not later than #bd      
months after the date of enactment of   
this ,act1 the ,comptroller ,general of 
the ,united ,states shall initiate an   

evaluation of1 and submit to ,congress a
 report on1 the inpatient and outpatient
 treatment capacity1 availability1 and  
needs of the ,united ,states1 including1
 to the extent data are available--     
7#a7 the capacity of acute residential  
or inpatient detoxification programs2   
7#b7 the capacity of inpatient clinical 
stabilization programs1 transitional    
residential support services1 and       
residential rehabilitation programs2    
7#c7 the capacity of demographic        
specific residential or inpatient       
treatment programs1 such as those       
designed for pregnant women or          
adolescents2  7#d7 geographical         
differences of the availability of      
residential and outpatient treatment and
 recovery options for substance use     
disorders across the continuum of care2 
7#e7 the availability of residential and
 outpatient treatment programs that     
offer treatment options based on        
reliable scientific evidence of efficacy
 for the treatment of substance use     

disorders1 including the use of ,food   
and ,drug ,administration-approved      
medicines and evidence-based            
nonpharmacological therapies2  7#f7 the 
number of patients in residential and   
specialty outpatient treatment services 
for substance use disorders2  7#g7 an   
assessment of the need for residential  
and outpatient treatment for substance  
use disorders across the continuum of   
care2  7#h7 the availability of         
residential and outpatient treatment    
programs to ,american ,indians and      
,alaska ,natives through an ,indian     
health program 7as defined by section #d
 of the ,indian ,health ,care           
,improvement ,act 7#be ,u4,s4,c4        
#afjc772 and  7#i7 the barriers         
7including technological barriers7 at   
the ,federal1 ,state1 and local levels  
to real-time reporting of de-identified 
information on drug overdoses and ways  
to overcome such barriers4